FdaApplication
ANDA 213052
Identifiers
- fda_app_no: ANDA213052
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2023-03-31 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PRAZOSIN HYDROCHLORIDE | PRAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE;ORAL |
| PRAZOSIN HYDROCHLORIDE | PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE;ORAL |
| PRAZOSIN HYDROCHLORIDE | PRAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE;ORAL |
3 products